Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers.

× No keyword cloud information.

35 in total

1. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.

Authors: R B Kim; C Wandel; B Leake; M Cvetkovic; M F Fromm; P J Dempsey; M M Roden; F Belas; A K Chaudhary; D M Roden; A J Wood; G R Wilkinson
Journal: Pharm Res Date: 1999-03 Impact factor: 4.200

2. 5,7-Dimethoxyflavone and multiple flavonoids in combination alter the ABCG2-mediated tissue distribution of mitoxantrone in mice.

Authors: Guohua An; Fang Wu; Marilyn E Morris
Journal: Pharm Res Date: 2011-01-29 Impact factor: 4.200

3. Altered intracellular pH regulation in cells with high levels of P-glycoprotein expression.

Authors: Gregory Young; Luis Reuss; Guillermo A Altenberg
Journal: Int J Biochem Mol Biol Date: 2010-06-03

4. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation.

Authors: F J Sharom; P Lu; R Liu; X Yu
Journal: Biochem J Date: 1998-08-01 Impact factor: 3.857

Review 5. Diagnostics of multidrug resistance in cancer.

Authors: G Szakács; K Jakab; F Antal; B Sarkadi
Journal: Pathol Oncol Res Date: 1998 Impact factor: 3.201

6. Cyclosporin analogs inhibit in vitro growth of Cryptosporidium parvum.

Authors: M E Perkins; T W Wu; S M Le Blancq
Journal: Antimicrob Agents Chemother Date: 1998-04 Impact factor: 5.191

Review 7. Role of P-glycoprotein in pharmacokinetics: clinical implications.

Authors: Jiunn H Lin; Masayo Yamazaki
Journal: Clin Pharmacokinet Date: 2003 Impact factor: 6.447

8. Detection of recombinant P-glycoprotein in multidrug resistant cultured cells.

Authors: U A Germann
Journal: Mol Biotechnol Date: 2000-02 Impact factor: 2.695

9. Structural determinants of P-glycoprotein-mediated transport of glucocorticoids.

Authors: Charles R Yates; Cheng Chang; Jeffrey D Kearbey; Kazuto Yasuda; Erin G Schuetz; Duane D Miller; James T Dalton; Peter W Swaan
Journal: Pharm Res Date: 2003-11 Impact factor: 4.200

10. The P-glycoprotein inhibitor GF120918 modulates Ca2+-dependent processes and lipid metabolism in Toxoplasma gondii.

Authors: Iveta Bottova; Ursula Sauder; Vesna Olivieri; Adrian B Hehl; Sabrina Sonda
Journal: PLoS One Date: 2010-04-08 Impact factor: 3.240